Contrasting Solana (NASDAQ:HSDT) & Disaboom (OTCMKTS:MEDH)

Disaboom (OTCMKTS:MEDH) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Insider and Institutional Ownership

18.6% of Solana shares are owned by institutional investors. 17.2% of Solana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for Disaboom and Solana, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
Solana	1	0	0	0	1.00

Valuation and Earnings

This table compares Disaboom and Solana”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.78	-$170,000.00	N/A	N/A
Solana	$520,000.00	11.42	-$11.74 million	($1,976.28)	0.00

Disaboom has higher revenue and earnings than Solana.

Volatility and Risk

Disaboom has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Solana has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

Profitability

This table compares Disaboom and Solana’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	-3.05%	N/A	N/A
Solana	-7,215.25%	-699.93%	-415.24%

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.